Top compounds associated with response to NAT9


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.006
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.093 0.006
mRNA MS-275 FIMM pan-cancer AAC 0.34 0.007
mRNA TAE684 GDSC1000 pan-cancer AAC -0.14 0.007
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.088 0.007
mRNA AMG-706 FIMM pan-cancer AAC 0.41 0.008
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.077 0.009
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.097 0.01
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA JQ-1 GDSC1000 pan-cancer AAC 0.081 0.01
Download CSV